Location History:
- Houston, TX (US) (2008)
- Bellaire, TX (US) (2010)
Company Filing History:
Years Active: 2008-2010
Title: Innovations of Marya F McCarty
Introduction
Marya F McCarty is a notable inventor based in Bellaire, Texas. She has made significant contributions to the field of medical research, particularly in the area of angiogenesis and tumor treatment. With a total of two patents to her name, her work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Marya's latest patents focus on the role of Beta-2-glycoprotein 1 as an inhibitor of angiogenesis. The first patent describes a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked β2-Glycoprotein 1 (β2GP1) to cells associated with the tissue. The presence of β2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. Additionally, this patent outlines a method for treating tumors by administering β2GP1 to the tumor. The second patent reiterates these findings, emphasizing the importance of β2GP1 in inhibiting angiogenesis and its potential therapeutic applications.
Career Highlights
Marya F McCarty is affiliated with the University of Texas System, where she continues her research and innovation. Her work has garnered attention for its implications in cancer treatment and regenerative medicine.
Collaborations
Marya collaborates with esteemed colleagues, including Alan J Schroit and Krishnakumar Balasubramanian, who contribute to her research endeavors and enhance the impact of her work.
Conclusion
Marya F McCarty's contributions to the field of medical research through her patents on Beta-2-glycoprotein 1 highlight her innovative spirit and dedication to improving health outcomes. Her work exemplifies the intersection of research and practical application in the medical field.